Menu
Search
|

Menu

Close
X

Amedica Corp AMDA.OQ (NASDAQ Stock Exchange Capital Market)

0.33 USD
+0.02 (+5.81%)
As of 7:20 PM BST
chart
Previous Close 0.31
Open 0.31
Volume 260,861
3m Avg Volume 199,773
Today’s High 0.33
Today’s Low 0.28
52 Week High 6.92
52 Week Low 0.18
Shares Outstanding (mil) 36.26
Market Capitalization (mil) 10.59
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
3.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
4
FY17
11
FY16
15
FY15
19
EPS (USD)
FY18
-2.298
FY17
-3.025
FY16
-14.863
FY15
-86.236
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.75
Price to Sales (TTM)
vs sector
0.70
5.74
Price to Book (MRQ)
vs sector
0.57
5.00
Price to Cash Flow (TTM)
vs sector
--
23.28
Total Debt to Equity (MRQ)
vs sector
48.79
16.89
LT Debt to Equity (MRQ)
vs sector
0.00
12.55
Return on Investment (TTM)
vs sector
-107.64
14.60
Return on Equity (TTM)
vs sector
-162.11
16.33

EXECUTIVE LEADERSHIP

B. Sonny Bal
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Since 2016
Salary: $79,423.00
Bonus: --
Bryan McEntire
Chief Technology Officer, Since 2012
Salary: $217,995.00
Bonus: $5,000.00
Dana Lyons
Vice President - Sales and Marketing, Since 2016
Salary: --
Bonus: --
Eric Stookey
Independent Director, Since 2014
Salary: --
Bonus: --
David Truetzel
Independent Director, Since
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

1885 West 2100 Street
SALT LAKE CITY   UT   84119

Phone: +1801.8393516

Amedica Corporation, incorporated on December 10, 1996, is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company has developed a femoral head that is made from its solid silicon nitride, which could be used for total hip replacement product candidates. It has also developed a femoral condyle design made from its solid silicon nitride. The Company is incorporating its silicon nitride technology into components for use in total hip and knee replacement product candidates. The Company markets and sells its products to surgeons and hospitals in the United States, and certain markets in Europe and South America.

SPONSORED STORIES